• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昂丹司琼注射液连续使用对顺铂所致恶心呕吐的止吐效果及安全性

[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis].

作者信息

Akasaka Y, Taguchi T, Ota K, Furue H, Niitani H, Tsukagoshi S, Ariyoshi Y, Ikeda M, Ohta J, Suminaga M

机构信息

Department of Urology, Jikei University School of Medicine, Tokyo, Japan.

出版信息

Gan To Kagaku Ryoho. 1992 Aug;19(9):1359-74.

PMID:1386977
Abstract

Anti-emetic effect, safety and clinical usefulness of Ondansetron injection given in the dose of 4 mg once daily by intravenous administration for 3-5 consecutive days were examined in patients receiving a high single dose (not less than 50 mg/m2 or over 75 mg/body) and lower multiple doses (over 15-20 mg/m2 once daily, for 3-5 consecutive days) of cisplatin. Efficacy rates of inhibitory effects on nausea and emesis in patients receiving the high single dose of cisplatin were 76% on the 1st day, 67% on the 2nd day and 78% on the 3rd day, the average being 71% (86/121 cases) for the 3 days. Those in patients receiving lower multiple doses of cisplatin were 83% on the 1st day, 78% on the 2nd day, 61% on the 3rd day, 65% on the 4th day and 57% on the 5th day, the average being 72% (13/18 cases) for the 3-5 days. Side effects were observed in 15 cases out of 207 (1st course, 182 cases; 2nd course, 21 cases; 3rd course, 4 cases), and major symptoms were headache and fever. Also, abnormalities in clinical laboratory findings attributable to Ondansetron were observed in 13 cases, mainly consisting of elevation of the hepatic function values. From the above, Ondansetron injection which showed sufficient anti-emetic effects on acute emesis and delayed emesis induced by a high single dose or lower multiple doses of cisplatin with its once daily intravenous dose given for 3-5 consecutive days, were considered a safe and clinically useful anti-emetic.

摘要

对接受高单次剂量(不少于50mg/m²或超过75mg/体)和顺铂低多次剂量(每日超过15 - 20mg/m²,连续3 - 5天)的患者,研究了昂丹司琼注射液每日静脉注射1次、每次4mg、连续3 - 5天给药的止吐效果、安全性及临床实用性。接受高单次剂量顺铂的患者,第1天对恶心和呕吐的抑制有效率为76%,第2天为67%,第3天为78%,3天的平均有效率为71%(121例中的86例)。接受低多次剂量顺铂的患者,第1天为83%,第2天为78%,第3天为61%,第4天为65%,第5天为57%,3 - 5天的平均有效率为72%(18例中的13例)。207例患者中有15例出现副作用(第1疗程182例;第2疗程21例;第3疗程4例),主要症状为头痛和发热。此外,有13例观察到与昂丹司琼有关的临床实验室检查异常,主要为肝功能值升高。综上所述,昂丹司琼注射液对高单次剂量或低多次剂量顺铂引起的急性呕吐和迟发性呕吐显示出足够的止吐效果,每日静脉给药1次、连续3 - 5天,被认为是一种安全且临床有用的止吐药。

相似文献

1
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis].昂丹司琼注射液连续使用对顺铂所致恶心呕吐的止吐效果及安全性
Gan To Kagaku Ryoho. 1992 Aug;19(9):1359-74.
2
[Clinical evaluation of ondansetron (injection of a single intravenous dose) against nausea and emesis associated with anti-cancer drugs--dose-finding study in patients receiving cisplatin].[昂丹司琼(单次静脉注射)对抗癌药物所致恶心和呕吐的临床评价——顺铂治疗患者的剂量探索研究]
Gan To Kagaku Ryoho. 1992 Aug;19(9):1333-45.
3
[Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].昂丹司琼新剂型(速崩片)GG032X片对顺铂所致恶心和呕吐的临床疗效
Gan To Kagaku Ryoho. 1997 Jun;24(8):995-1011.
4
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin].昂丹司琼片多次给药对顺铂相关恶心和呕吐的止吐作用研究
Gan To Kagaku Ryoho. 1992 Sep;19(11):1879-90.
5
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs].[连续3 - 5天每日口服一次SN - 307(昂丹司琼)对非铂类抗癌药物所致恶心和呕吐的抑制作用、安全性及有效性研究]
Gan To Kagaku Ryoho. 1992 Sep;19(11):1891-903.
6
[Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs].[多剂量静脉注射昂丹司琼对接受非铂类抗癌药物治疗患者的止吐效果及安全性研究]
Gan To Kagaku Ryoho. 1992 Aug;19(9):1375-85.
7
[Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo].昂丹司琼片与安慰剂双盲对照的止吐效果及安全性
Gan To Kagaku Ryoho. 1992 Oct;19(12):2057-70.
8
[Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo].
Gan To Kagaku Ryoho. 1992 Oct;19(12):2041-55.
9
[Examination of anti-emetic effect, safety and usefulness of single oral dose of ondansetron tablet in nausea and emesis induced by anti-cancer drugs--dose-finding study of ondansetron tablet in patients receiving non-platinum anti-cancer drugs].
Gan To Kagaku Ryoho. 1992 Aug;19(9):1347-57.
10
[Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].盐酸昂丹司琼与地塞米松联合使用对接受顺铂治疗的肺癌患者恶心呕吐的影响
Gan To Kagaku Ryoho. 1998 Dec;25(14):2275-81.

引用本文的文献

1
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.多日化疗患者多日止吐治疗的疗效与安全性:日本临床肿瘤学会《2023年止吐临床实践指南》的系统评价
Int J Clin Oncol. 2025 Jan;30(1):17-26. doi: 10.1007/s10147-024-02652-7. Epub 2024 Nov 12.